The guest editors, Dr. William Huang and Dr. Ezequiel Becher, have assembled a state-of-the art issue devoted to Advanced and Metastatic Renal Cell Carcinoma (RCC). They have secured expert authors to contribute clinical reviews on the important topics involving treating and managing patients with RCC. Specific articles are devoted to the following topics: Imaging for Metastatic RCC; Adjuvant Therapy for Localized High Risk RCC; Current Standards for Therapeutic Sequencing for Advanced RCC; Role of Lymphadenectomy in patients with advanced RCC; Cytoreductive Nephrectomy in the Era of TKI/IO - Who, When and Why; Minimally Invasive Surgery for Patients with Locally Advanced and Metastatic Disease RCC; Evolving Role of Urologists in the Management of Advanced RCC; Neoadjuvant Therapy for Locally Advanced RCC; Epidemiology and Risk Assessment/Biomarkers for Patients with Advanced RCC; Radiation Therapy for Patients with Metastatic RCC; Evolving Role of Metastatectomy for Patients with Metastatic RCC; and Management of Non-Clear Cell Metastatic RCC. Readers will come away with the information they need to treat and manage patients and to improve outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Urologic Clinics of North America - p. xi 7. Preface - p. xiii 8. Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma - p. 271 9. Imaging for Metastatic Renal Cell Carcinoma - p. 281 10. Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma - p. 293 11. Sequencing Therapies for Metastatic Renal Cell Carcinoma - p. 305 12. Management of Metastatic Renal Cell Carcinoma with Variant Histologies - p. 319 13. Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma - p. 329 14. Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma - p. 345 15. Cytoreductive Nephrectomy in the Era of Tyrosine Kinase and Immuno-Oncology Checkpoint Inhibitors - p. 359 16. The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma - p. 371 17. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma - p. 379 18. Minimally Invasive Surgery for Patients with Locally Advanced and/or Metastatic Renal Cell Carcinoma - p. 389 19. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma - p. 399
The guest editors, Dr. William Huang and Dr. Ezequiel Becher, have assembled a state-of-the art issue devoted to Advanced and Metastatic Renal Cell Carcinoma (RCC). They have secured expert authors to contribute clinical reviews on the important topics involving treating and managing patients with RCC. Specific articles are devoted to the following topics: Imaging for Metastatic RCC; Adjuvant Therapy for Localized High Risk RCC; Current Standards for Therapeutic Sequencing for Advanced RCC; Role of Lymphadenectomy in patients with advanced RCC; Cytoreductive Nephrectomy in the Era of TKI/IO - Who, When and Why; Minimally Invasive Surgery for Patients with Locally Advanced and Metastatic Disease RCC; Evolving Role of Urologists in the Management of Advanced RCC; Neoadjuvant Therapy for Locally Advanced RCC; Epidemiology and Risk Assessment/Biomarkers for Patients with Advanced RCC; Radiation Therapy for Patients with Metastatic RCC; Evolving Role of Metastatectomy for Patients with Metastatic RCC; and Management of Non-Clear Cell Metastatic RCC. Readers will come away with the information they need to treat and manage patients and to improve outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Urologic Clinics of North America - p. xi 7. Preface - p. xiii 8. Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma - p. 271 9. Imaging for Metastatic Renal Cell Carcinoma - p. 281 10. Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma - p. 293 11. Sequencing Therapies for Metastatic Renal Cell Carcinoma - p. 305 12. Management of Metastatic Renal Cell Carcinoma with Variant Histologies - p. 319 13. Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma - p. 329 14. Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma - p. 345 15. Cytoreductive Nephrectomy in the Era of Tyrosine Kinase and Immuno-Oncology Checkpoint Inhibitors - p. 359 16. The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma - p. 371 17. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma - p. 379 18. Minimally Invasive Surgery for Patients with Locally Advanced and/or Metastatic Renal Cell Carcinoma - p. 389 19. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma - p. 399
